COLLECTION OF NEXT-GENERATION SEQUENCING (NGS) DATA AND USE OF NOVEL DRUGS IN ACUTE LEUKEMIA PATIENTS Group Acute Leukemia Working Party (ALWP) Type of transplant Principal investigator Prof M. Mohty
Outcome after allogeneic SCT for MLL-PTD AML Group Acute Leukemia Working Party (ALWP) Principal investigator Marta Pratcorona
Prevalence and outcome of central nervous system (CNS) relapse after allogeneic stem cell transplantation (HSCT) in patients suffering from acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL) Group Acute Leukemia Working Party (ALWP) Principal investigator Sabine BLUM , Yves Chalandon
Efficacy and Toxicity of ponatinib and 2nd generation TKI given after allogeneic SCT in Ph+ adult ALL. Group Acute Leukemia Working Party (ALWP) Principal investigator Klaus HIRSCHBUEHL
Elderly AML: A randomised Phase III study comparing conventional chemotherapy to low dose total body irradiation-based conditioning and hematopoietic stem cell transplantation from related and unrelated donors as consolidation therapy for older patients with AML in 1st complete remission Group Acute Leukemia Working Party (ALWP) Type of transplant Principal investigator Dietger Niederwieser